VolitionRx Limited (VNRX)
NYSEAMERICAN: VNRX · Real-Time Price · USD
0.6847
+0.0170 (2.55%)
Jul 14, 2025, 4:00 PM - Market closed

VolitionRx Revenue

VolitionRx had revenue of $246.39K in the quarter ending March 31, 2025, with 43.64% growth. This brings the company's revenue in the last twelve months to $1.31M, up 64.15% year-over-year. In the year 2024, VolitionRx had annual revenue of $1.23M with 59.10% growth.

Revenue (ttm)
$1.31M
Revenue Growth
+64.15%
P/S Ratio
46.02
Revenue / Employee
$15,392
Employees
85
Market Cap
70.54M

Revenue Chart

Revenue History

Fiscal Year End Revenue Change Growth
Dec 31, 2024 1.23M 458.21K 59.10%
Dec 31, 2023 775.30K 468.91K 153.04%
Dec 31, 2022 306.39K 216.36K 240.30%
Dec 31, 2021 90.04K 76.60K 570.25%
Dec 31, 2020 13.43K -3.66K -21.43%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
UnitedHealth Group 410.06B
Johnson & Johnson 89.33B
Merck & Co. 63.92B
AbbVie 57.37B
AstraZeneca 54.98B
Novartis AG 53.22B
Eli Lilly and Company 49.00B
Novo Nordisk 43.92B
Revenue Rankings